Actively Recruiting
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.
Led by Mucosa Innovations, S.L. · Updated on 2026-04-15
63
Participants Needed
1
Research Sites
228 weeks
Total Duration
On this page
Sponsors
M
Mucosa Innovations, S.L.
Lead Sponsor
H
HM Sanchinarro University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The use of a novel topical mucosa composition (XCM-OM118) comprising 2-(trimethylazaniumyl) acetate; (2R,3R,4S)-pentane-1,2,3,4,5-pentol; Hexadecanoic acid; (9Z, 12Z)-octadeca-9,12-dienoic acid; octadecanoic acid; (Z)-hexadec-9-enoic acid; (Z)-octadec-9-enoic acid) delivered as a gel and a mouthwash is to be studied in regard to its effect on the incidence of severe oral mucositis in Head \& Neck cancer radiated patients. Patient reported outcome measures seem to be an effective tool to obtain a greater knowledge of the physical and emotional state of patients, being used in this study to assess quality of life of Head \& Neck cancer radiated patients.
CONDITIONS
Official Title
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Head & Neck cancer who will undergo radiotherapy (with or without concomitant chemotherapy)
- Patients who are able to read, understand, and complete the questionnaire
- Patients over 18 years of age
- Patients who have completed radiotherapy treatment at least 6 months before study enrolment (for chronic phase)
You will not qualify if you...
- Patients who are unable to properly use the products
- Patients who do not consent to participate in the study
- Patients who were being treated for another type of cancer (acute phase)
- Patients using medications such as pilocarpine, cevimeline, etc., to treat xerostomia (chronic phase)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mucosa Innovations S.L.
Madrid, Madrid, Spain, 28023
Actively Recruiting
Research Team
J
Jorge Rodríguez-Vilaboa
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here